REVELATION BIOSCIENCES, INC. (REVB) Net income 2019–2025
REVELATION BIOSCIENCES, INC. (REVB) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$8.9MFY2025 · since FY2019: -$3,638 → -$8.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$8.9M | +40.7% |
| FY2024 | -$15.0M | -12405.6% |
| FY2023 | -$120,254 | +98.9% |
| FY2022 | -$10.8M | +9.7% |
| FY2021 | -$12.0M | -635.2% |
| FY2020 | -$1.6M | -44718.6% |
| FY2019 | -$3,638 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More REVB financial trends
REVB RevenueREVB Net marginREVB Gross profitREVB Gross marginREVB Operating incomeREVB Operating marginREVB Operating cash flowREVB Free cash flowREVB Capital expendituresREVB Return on equityREVB Stock buybacksREVB Dividends paidREVB Total assetsREVB Total liabilitiesREVB Shareholders’ equityREVB overview →